Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale President and CEO sold 3,331 shares at $7.00 ($23,307)
  3. 4 Open-market sale EVP, CFO and COO sold 1,211 shares at $7.00 ($8,473)
  4. 4 Open-market sale EVP, Chief Regulatory Officer sold 1,059 shares at $7.00 ($7,410)
  5. 4 Grant or award EVP, CFO and COO acquired 34,050 shares (grant or award)
  6. 4 Open-market sale EVP, Chief Regulatory Officer sold 1,000 shares at $11.20 ($11,198)
  7. 4 Open-market sale EVP, CFO and COO sold 1,364 shares at $11.20 ($15,274)
  8. 4 Open-market sale President and CEO sold 1,664 shares at $11.20 ($18,633)
  9. 4 Grant or award President and CEO acquired 45,000 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market sale President and CEO sold 3,038 shares at an average $6.63 ($20,139)
  12. 4 Open-market sale EVP, Chief Sci. & Tech Officer sold 1,821 shares at an average $6.63 ($12,072)
  13. 4 Open-market sale EVP, Chief Legal Officer sold 1,158 shares at an average $6.63 ($7,677)
  14. 4 Open-market sale EVP, CFO sold 1,070 shares at an average $6.63 ($7,093)
  15. 4 Open-market sale EVP, Global Head RA & Quality sold 963 shares at an average $6.63 ($6,384)
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market sale President and CEO sold 81,506 shares at $0.62 ($50,289)
  18. 4 Open-market sale EVP, Chief Sci. & Tech Officer sold 42,899 shares at $0.62 ($26,469)
  19. 4 Open-market sale EVP, Chief Legal Officer sold 32,401 shares at $0.62 ($19,991)
  20. 4 Open-market sale EVP, CFO sold 28,648 shares at $0.62 ($17,676)

Page 3 of 33 · 644 filings